NRG-GU007

Study Title: 
Randomized Phase II Trial of Niraparib with Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (with Initial Phase I)
Lead Group: 
Status: 
Review Status: